Related Experiment Videos
Regression of diffuse osteosclerosis in hairy cell leukaemia after treatment with interferon
G E Verhoef1, C De Wolf-Peeters, P Zachee
1Department of Haematology, University Hospital Gasthuisberg, Leuven, Belgium.
British Journal of Haematology
|September 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Myelofibrosis patients in Belgium: disease characteristics.
Acta clinica Belgica·2014
Plerixafor prescription modalities in autologous haematopoietic stem cell mobilization in Belgium.
Acta clinica Belgica·2014
Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Chromosome 1p abnormalities in B non Hodgkin's lymphoma.
Leukemia & lymphoma·2011
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.
British journal of haematology·2026
Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.
British journal of haematology·2026
Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft-versus-host disease.
British journal of haematology·2026
Loss of LRRK2 Protects Against Ox-LDL-Induced Endothelial Oxidative Damage Via NRF2.
Molecular and cellular biology·2026
A Rare t(1;11)(q42;q23) Rearrangement with Trisomy 8 and Trisomy 21 in a Pediatric Acute Myeloid Leukemia Patient with Aberrant CD7 Expression and Jacob Syndrome: Diagnostic Value of Conventional Cytogenetics and Fluorescence in Situ Hybridization in a Rapidly Fatal Case.
Journal of the Association of Genetic Technologists·2026
Targeting Compensatory AKT Activation Overcomes Resistance to AXL Inhibition in Acute Lymphoblastic Leukemia.
Molecular cancer therapeutics·2026
Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.
Clinical pharmacology and therapeutics·2026